Excess length of stay attributable to clostridium difficile infection (CDI) in the acute care setting: A multistate model

Infection Control and Hospital Epidemiology

Volumn 36, Issue 9, 2015, Pages 1024-1030

  Stevens, Vanessa W ^a,b   Khader, Karim ^a,c   Nelson, Richard E ^a,c   Jones, Makoto ^a,c   Rubin, Michael A ^a,c   Brown, Kevin A ^a,c   Evans, Martin E ^a   Greene, Tom ^a,c   Slade, Eric ^d   Samore, Matthew H ^a,c  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF UTAH   (United States)

^c UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^d Health Care Answers   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BOOTSTRAPPING; CHARLSON COMORBIDITY INDEX; CLOSTRIDIUM DIFFICILE INFECTION; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; ELIXHAUSER COMORBIDITY INDEX; EMERGENCY CARE; FEMALE; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MODEL; MULTISTATE MODEL; RETROSPECTIVE STUDY; TIME; VERY ELDERLY; VETERANS HEALTH; ECONOMICS; ENTEROCOLITIS, PSEUDOMEMBRANOUS; MIDDLE AGED; PEPTOCLOSTRIDIUM DIFFICILE; PUBLIC HOSPITAL; SEVERITY OF ILLNESS INDEX; STATISTICAL BIAS; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA; UNITED STATES;

AGED; AGED, 80 AND OVER; BIAS (EPIDEMIOLOGY); CLOSTRIDIUM DIFFICILE; ENTEROCOLITIS, PSEUDOMEMBRANOUS; FEMALE; HOSPITALS, VETERANS; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; MODELS, STATISTICAL; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; UNITED STATES;

EID: 84958542889     PISSN: 0899823X     EISSN: 15596834     Source Type: Journal    
DOI: 10.1017/ice.2015.132     Document Type: Article

References (35)

1. Miller BA, Chen LF, Sexton DJ, Anderson DJ. Comparison of the burdens of hospital-onset, healthcare facility–associated Clostridium difficile infection and of healthcare-associated infection due to methicillin-resistant Staphylococcus aureus in community hospitals. Infect Control Hosp Epidemiol 2011;32:387–390.
2. Butt E, Foster J, Keedwell E, et al. Derivation and validation of a simple, accurate and robust prediction rule for risk of mortality in patients with Clostridium difficile infection. BMC Infect Dis 2013;13:316.
3. Pepin J, Valiquette L, Alary ME, et al. Clostridium difficileassociated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity. CMAJ 2004;171:466–472.
4. McDonald LC, Owings M, Jernigan DB. Clostridium difficile infection in patients discharged from US short-stay hospitals, 1996–2003. Emerg Infect Dis 2006;12:409–415.
5. Reveles KR, Lee GC, Boyd NK, Frei CR. The rise in Clostridium difficile infection incidence among hospitalized adults in the United States: 2001–2010. Am J Infect Control 2014;42: 1028–1032.
6. McDonald LC, Killgore GE, Thompson A, et al. An epidemic, toxin gene-variant strain of Clostridium difficile. New Engl J Med 2005;353:2433–2441.
7. Lim SK, Stuart RL, Mackin KE, et al. Emergence of a ribotype 244 strain of Clostridium difficile associated with severe disease and related to the epidemic ribotype 027 strain. Clin Infect Dis 2014;58:1723–1730.
8. Dumyati G, Stevens V, Hannett GE, et al. Community-associated Clostridium difficile infections, Monroe County, New York, USA. Emerg Infect Dis 2012;18:392–400.
9. Ghantoji SS, Sail K, Lairson DR, DuPont HL, Garey KW. Economic healthcare costs of Clostridium difficile infection: a systematic review. J Hosp Infect 2010;74:309–318.
10. Dubberke ER, Olsen MA. Burden of Clostridium difficile on the healthcare system. Clin Infect Dis 2012;55:S88–S92.
11. Gabriel L, Beriot-Mathiot A. Hospitalization stay and costs attributable to Clostridium difficile infection: a critical review. J Hosp Infect 2014;88:12–21.
12. Barnett AG, Beyersmann J, Allignol A, Rosenthal VD, Graves N, Wolkewitz M. The time-dependent bias and its effect on extra length of stay due to nosocomial infection. Value Health 2011;14:381–386.
13. Graves N, Harbarth S, Beyersmann J, Barnett A, Halton K, Cooper B. Healthcare epidemiology: estimating the cost of health care–associated infections: mind your p’s and q’s. Clin Infect Dis 2010;50:1017–1021.
14. Graves NP, Barnett AGP, Halton KP, et al. The importance of good data, analysis, and interpretation for showing the economics of reducing healthcare-associated infection. Infect Control Hosp Epidemiol 2011;32:927–928.
15. Beyersmann J, Kneib T, Schumacher M, Gastmeier P. Nosocomial infection, length of stay, and time-dependent bias. Infect Control Hosp Epidemiol 2009;30:273–276.
16. Samore MH, Harbarth S. A methodologically focused review of the literature in hospital epidemiology and infection control. In: Mayhall CG, ed. Hospital Epidemiology and Infection Control, 3rd ed. Phildelphia, PA: Lipincott, Williams, and Wilkins, 2004.
17. Vrijens F, Hulstaert F, Van de Sande S, Devriese S, Morales I, Parmentier Y. Hospital-acquired, laboratory-confirmed bloodstream infections: linking national surveillance data to clinical and financial hospital data to estimate increased length of stay and healthcare costs. J Hosp Infect 2010;75:158–162.
18. Commenges D. Multi-state models in epidemiology. Lifetime Data Anal 1999;5:315–327.
19. Mitchell BG, Gardner A, Barnett AG, Hiller JE, Graves N. The prolongation of length of stay because of Clostridium difficile infection. Am J Infect Control 2014;42:164–167.
20. van Kleef E, Green N, Goldenberg SD, et al. Excess length of stay and mortality due to Clostridium difficile infection: a multi-state modelling approach. J Hosp Infect 2014;88:213–217.
21. Lagu T, Stefan MS, Haessler S, et al. The impact of hospital-onset Clostridium difficile infection on outcomes of hospitalized patients with sepsis. J Hosp Med 2014;9:411–417.
22. Ampel NM. Plagues: what’s past is present: thoughts on the origin and history of new infectious diseases. Rev Infect Dis 1991;13: 658–665.
23. Hebden JN, Anttila A, Allen-Bridson K, Morrell GC, Wright M-O, Horan T. Healthcare-associated infections studies project: an American Journal of Infection Control and National Healthcare Safety Network data quality collaboration—LabID Clostridium difficile event 2013. Am J Infect Control 2013;41:916–917.
24. Cohen Stuart H, Gerding Dale N, Johnson S, et al. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA). Infect Control Hosp Epidemiol 2010;31:431–455.
25. Gagne JJ, Glynn RJ, Avorn J, Levin R, Schneeweiss S. A combined comorbidity score predicted mortality in elderly patients better than existing scores. J Clin Epidemiol 2011;64:749–759.
26. Barnett AG, Batra R, Graves N, Edgeworth J, Robotham J, Cooper B. Using a longitudinal model to estimate the effect of methicillinresistant Staphylococcus aureus infection on length of stay in an intensive care unit. Am J Epidemiol 2009;170: 1186–1194.
27. Allignol AS, Schumacher M, Beyersmann J. Empirical transition matrix of multi-state models: the etm package. J Stat Soft 2011;38:1–15.
28. DiCiccio TJ, Efron B. Bootstrap confidence intervals. Stat Sci 1996;11:189–212.
29. Lofgren ET, Cole SR, Weber DJ, Anderson DJ, Moehring RW. Hospital-acquired Clostridium difficile infections: estimating allcause mortality and length of stay. Epidemiology 2014; 25:570–575.
30. Wolkewitz MA, Allignol A, Schumacher M, Beyersmann J. Two pitfalls in survival analyses of time-dependent exposure: a case study in a cohort of Oscar nominees. Am Statistician 2010;64:205–211.
31. Cheknis AK, Sambol SP, Davidson DM, et al. Distribution of Clostridium difficile strains from a North American, European and Australian trial of treatment for C. difficile infections: 2005–2007. Anaerobe 2009;15:230–233.
32. Walker AS, Eyre DW, Wyllie DH, et al. Relationship between bacterial strain type, host biomarkers, and mortality in Clostridium difficile infection. Clin Infect Dis 2013;56:1589–1600.
33. Baier RMPH, Morphis BBS, Marsella MRNBS, Mermel LADOS. Clostridium difficile surveillance: a multicenter comparison of LabID events and use of standard definitions. Infect Control Hosp Epidemiol 2013;34:653–655.
34. Gase KA, Haley VB, Xiong K, Van Antwerpen C, Stricof RL. Comparison of 2 Clostridium difficile surveillance methods: National Healthcare Safety Network’s laboratory-identified event reporting module versus clinical infection surveillance. Infect Control Hosp Epidemiol 2013;34:284–290.
35. NCHS. Data highlights: average length of stay and days of care in the National Hospital Discharge Survey. Atlanta, GA: Centers for Disease Control and Prevention, 2010.